Intervacc Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 12
Employees
  • Stock Symbol
  • IVACC
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $10.30
  • (As of Friday Closing)

Intervacc General Information

Description

Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Stock Exchange
STO
Primary Office
  • Box 112
  • Hägersten
  • 129 22 Stockholm
  • Sweden
+46 08-120 000 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intervacc Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.30 $10.25 $2.39 - $11.17 $517M 50.2M 202K -$0.06

Intervacc Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 426,659 303,734 77,135 23,014
Revenue 539 518 1,283 4,091
EBITDA (2,207) (2,115) (2,293) (1,857)
Net Income (2,895) (2,777) (2,949) (3,160)
Total Assets 39,317 43,311 25,356 22,546
Total Debt 0 47 80 118
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Intervacc Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Intervacc‘s full profile, request access.

Request a free trial

Intervacc Executive Team (9)

Name Title Board Seat Contact Info
Andreas Andersson Chief Executive Officer
Jan Persson Chief Financial Officer
Patrik Hellberg Chief Information Officer
Andrew Waller Chief Scientific Officer
Tim Wood Ph.D CMC and Regulatory
You’re viewing 5 of 9 executive team members. Get the full list »

Intervacc Board Members (8)

Name Representing Role Since
00000 0000 Intervacc Board Member 000 0000
00ö00 00ö000000 Self Chairman 000 0000
000000 00000 Self Board Member 000 0000
You’re viewing 3 of 8 board members. Get the full list »

Intervacc Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intervacc Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intervacc‘s full profile, request access.

Request a free trial

Intervacc Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0ä0000000 25-Mar-2014 0000000000 Medical Supplies
To view Intervacc’s complete investments history, request access »